Secretory immunity in influenza. 1979

Y S Shvartsman, and S K Grigorieva

The dynamics of secretory antibody formation, the duration of secretory antibody preservation, and changes in the concentration of secretory antibodies to antigens other than influenza virus were studied in 64 patients with influenza A, 105 patients with influenza B, and 23 persons who had had influenza A. Severe forms of influenza A were accompanied by antibody accumulation in sera and nasal secretions; in some cases of mild forms of this infection, this process was limited by the humoral immunity system. In the first days of severe forms, transudation of antibodies from sera to nasal secretions was noted. Secretory antibodies to influenza A virus were preserved at titers of greater than or equal to 1:4 for four to eight months in persons with mild forms of the disease and for more than eight months in those with severe influenza A complicated with pneumonia. Decreases in the titer of antibodies to agents other than influenza A virus, including influenza B virus, respiratory syncytial virus, adenovirus, and staphylococcus toxin, were demonstrated in association with rises in titers of antibody to influenza A virus. Among patients with influenza B, who were infected with a new influenza virus variant, the formation of circulating antibodies was more intensely stimulated than was the formation of secretory antibodies. No correlation between the level of IgA and the antibody titer in nasal secretions was found.

UI MeSH Term Description Entries
D007251 Influenza, Human An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. Grippe,Human Flu,Human Influenza,Influenza in Humans,Influenza,Flu, Human,Human Influenzas,Influenza in Human,Influenzas,Influenzas, Human
D008297 Male Males
D009297 Nasal Mucosa The mucous lining of the NASAL CAVITY, including lining of the nostril (vestibule) and the OLFACTORY MUCOSA. Nasal mucosa consists of ciliated cells, GOBLET CELLS, brush cells, small granule cells, basal cells (STEM CELLS) and glands containing both mucous and serous cells. Nasal Epithelium,Schneiderian Membrane,Epithelium, Nasal,Membrane, Schneiderian,Mucosa, Nasal
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D009980 Influenza A virus The type species of the genus ALPHAINFLUENZAVIRUS that causes influenza and other diseases in humans and animals. Antigenic variation occurs frequently between strains, allowing classification into subtypes and variants. Transmission is usually by aerosol (human and most non-aquatic hosts) or waterborne (ducks). Infected birds shed the virus in their saliva, nasal secretions, and feces. Alphainfluenzavirus influenzae,Avian Orthomyxovirus Type A,FLUAV,Fowl Plague Virus,Human Influenza A Virus,Influenza Virus Type A,Influenza Viruses Type A,Myxovirus influenzae-A hominis,Myxovirus influenzae-A suis,Myxovirus pestis galli,Orthomyxovirus Type A,Orthomyxovirus Type A, Avian,Orthomyxovirus Type A, Human,Orthomyxovirus Type A, Porcine,Pestis galli Myxovirus,Fowl Plague Viruses,Influenza A viruses,Myxovirus influenzae A hominis,Myxovirus influenzae A suis,Myxovirus, Pestis galli,Myxoviruses, Pestis galli,Pestis galli Myxoviruses,Plague Virus, Fowl,Virus, Fowl Plague
D003289 Convalescence The period of recovery following an illness. Convalescences
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000937 Antigen-Antibody Reactions The processes triggered by interactions of ANTIBODIES with their ANTIGENS. Antigen Antibody Reactions,Antigen-Antibody Reaction,Reaction, Antigen-Antibody,Reactions, Antigen-Antibody

Related Publications

Y S Shvartsman, and S K Grigorieva
January 1976, Advances in immunology,
Y S Shvartsman, and S K Grigorieva
January 1985, Zeitschrift fur arztliche Fortbildung,
Y S Shvartsman, and S K Grigorieva
March 1987, Ugeskrift for laeger,
Y S Shvartsman, and S K Grigorieva
January 1998, Pathobiology : journal of immunopathology, molecular and cellular biology,
Y S Shvartsman, and S K Grigorieva
January 1997, Voprosy virusologii,
Y S Shvartsman, and S K Grigorieva
January 1978, Advances in experimental medicine and biology,
Y S Shvartsman, and S K Grigorieva
January 2002, International review of neurobiology,
Y S Shvartsman, and S K Grigorieva
June 1976, Medizinische Monatsschrift,
Y S Shvartsman, and S K Grigorieva
January 1989, Voprosy virusologii,
Copied contents to your clipboard!